Which of the following best describes thought withdrawal delusions?

A. Recurrent eye plucking. There is no recognized disorder specifically involving eye plucking. However, repetitive behaviors targeting the eyes may be seen in severe body-focused repetitive behaviors (BFRBs) or obsessive-compulsive disorder (OCD)-related conditions.

B. Recurrent lip biting. While some individuals engage in compulsive lip biting, this behavior is not classified under excoriation disorder but may be part of body-focused repetitive behaviors (BFRBs) or impulse control disorders.

C. Recurrent skin picking. Excoriation disorder (dermatillomania) is a mental health condition characterized by compulsive skin picking, leading to tissue damage, infections, and scarring. It is classified under obsessive-compulsive and related disorders (OCRDs) in the DSM-5 and is often associated with anxiety, stress, or perfectionism.

D. Recurrent hair pulling. Trichotillomania (hair-pulling disorder) is a separate condition from excoriation disorder, involving compulsive hair pulling that results in noticeable hair loss. It is also classified under obsessive-compulsive and related disorders in the DSM-5.

A. Aripiprazole (Abilify) is a second-generation (atypical) antipsychotic with a lower risk of extrapyramidal symptoms (EPS) due to its partial dopamine agonist mechanism. It has a lower incidence of tardive dyskinesia and dystonia compared to typical antipsychotics.

B. Clozapine (Clozaril) has the lowest risk of EPS among antipsychotics because it weakly blocks D2 receptors and primarily targets serotonin (5-HT2A) receptors. However, it carries a high risk of agranulocytosis, sedation, and metabolic syndrome.

C. Lurasidone (Latuda) is a second-generation antipsychotic with a moderate risk of EPS, particularly akathisia (restlessness). However, it has a lower risk than first-generation (typical) antipsychotics like haloperidol.

D. Haloperidol (Haldol) is a first-generation (typical) antipsychotic with a high risk of EPS due to its strong dopamine (D2) receptor blockade. It is associated with dystonia, akathisia, parkinsonism, and tardive dyskinesia, making it the antipsychotic with the highest EPS risk in this list.